Zobrazeno 1 - 5
of 5
pro vyhledávání: '"I. A. Mednova"'
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 4, Pp 197-208 (2020)
Background. Schizophrenia is a socially significant mental illness with insufficiently studied etiology and pathogenesis. A number of hypotheses of schizophrenia pathogenesis (dopamine, glutamate, kinurenin and serotonin hypotheses) bring together th
Externí odkaz:
https://doaj.org/article/293fe6449c054b6a82619e3bf368f659
Autor:
E. G. Kornetova, A. A. Goncharova, I. A. Mednova, A. N. Kornetov, T. V. Saprina, O. E. Perchatkina, A. V. Semke
Publikováno v:
Bulletin of Siberian Medicine. 22:57-64
Objective: identify differences or comparability of constitutional-morphological characteristics and indicators of the fatty constitution between patients with schizophrenia and people with MetS and without mental disorders.Materials and methods. We
Publikováno v:
European Neuropsychopharmacology. 40:S313
Autor:
Anastasiia S Boiko, Anton J. M. Loonen, Elena G Kornetova, Svetlana A. Ivanova, I. A. Mednova
Publikováno v:
European Neuropsychopharmacology, 29, S115-S116. ELSEVIER SCIENCE BV
In the general population, metabolic syndrome (MetS) is associated with a 4 times relative risk of developing diabetes and approximately a 2-fold risk of coronary heart disease, stroke, and premature mortality [1]. In patients with schizophrenia the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c71a14c045fd0d36b20780d7810f2b
https://doi.org/10.26226/morressier.5b68175fb56e9b005965c631
https://doi.org/10.26226/morressier.5b68175fb56e9b005965c631
Publikováno v:
European Neuropsychopharmacology. 29:S585-S586